Evidence map›Paper›PMID 30834176›Full record

ArticleTranslational vision science & technology2019

Cross-Sectional and Longitudinal Assessment of the Ellipsoid Zone in Childhood-Onset Stargardt Disease.

Preena Tanna, Michalis Georgiou, Rupert W Strauss, Naser Ali, Neruban Kumaran, Angelos Kalitzeos, Kaoru Fujinami, Michel Michaelides

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Stargardt macular dystrophy and therapeutic approaches.The British journal of ophthalmology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Structural evaluation in inherited retinal diseases.The British journal of ophthalmology · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Preena TannaUCL Institute of Ophthalmology, University College London, London, UK.
Michalis GeorgiouUCL Institute of Ophthalmology, University College London, London, UK.
Rupert W StraussUCL Institute of Ophthalmology, University College London, London, UK.
Naser AliUCL Institute of Ophthalmology, University College London, London, UK.
Neruban KumaranUCL Institute of Ophthalmology, University College London, London, UK.
Angelos KalitzeosUCL Institute of Ophthalmology, University College London, London, UK.
Kaoru FujinamiUCL Institute of Ophthalmology, University College London, London, UK.
Michel MichaelidesUCL Institute of Ophthalmology, University College London, London, UK.
University College London · GBMoorfields Eye Hospital · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

purposeTo evaluate the reliability of ellipsoid zone (EZ) loss width and area measurements from spectral-domain optical coherence tomography (SD-OCT) images and track disease progression in childhood-onset Stargardt disease (STGD1).

methodsChildren with molecularly confirmed STGD1 (

resultsThe intra- and intergrader reliability of transverse EZ loss and area of EZ loss measurements at baseline for both graders was 0.99. The mean annual rate of transverse EZ loss (±standard deviation) was 279.5 ± 259.9 μm/y. The mean rate of area of EZ loss (±standard deviation) was 1.20 ± 1.29 mm

conclusionsThis is a prospective study on the quantification of EZ loss in children with STGD1 and highlights the reliability of SD-OCT in measuring EZ loss. High intra- and intergrader reliability was observed, with good ability to detect changes over time. TRANSLATIONAL RELEVANCE: Measuring the area of EZ loss was more sensitive compared with transverse EZ width loss measurements and will be valuable for natural history studies and clinical trials requiring sensitive and reliable structural endpoints.

Indexed as

ABCA4clinical trialsellipsoid zoneendpointsEZOCTretinaStargardt diseaseSTGD1

Identifiers

PMID30834176
PMCPMC6397016
OpenAlexW2919339081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.